HUE055742T2 - Gyorsan ható inzulin készítmények - Google Patents

Gyorsan ható inzulin készítmények

Info

Publication number: HUE055742T2
Authority: HU; Hungary
Prior art keywords: rapid; acting insulin; insulin compositions; compositions; acting
Prior art date: 2014-05-08

Application number

HUE19161129A

Other languages

English (en)

Inventor

Michael Edward Christe

Thomas Andrew Hardy

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-05-08

Filing date

2015-05-04

Publication date

2021-12-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53189204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE055742(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-05-04 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2021-12-28 Publication of HUE055742T2 publication Critical patent/HUE055742T2/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Hematology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

HUE19161129A 2014-05-08 2015-05-04 Gyorsan ható inzulin készítmények HUE055742T2 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201461990402P	2014-05-08	2014-05-08

Publications (1)

Publication Number	Publication Date
HUE055742T2 true HUE055742T2 (hu)	2021-12-28

Family

ID=53189204

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HUE15723388 HUE044370T2 (hu)	2014-05-08	2015-05-04	Gyorsan ható inzulin készítmények
HUE19161129A HUE055742T2 (hu)	2014-05-08	2015-05-04	Gyorsan ható inzulin készítmények

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
HUE15723388 HUE044370T2 (hu)	2014-05-08	2015-05-04	Gyorsan ható inzulin készítmények

Country Status (36)

Country	Link
US (2)	US9439952B2 (hu)
EP (3)	EP3943155A1 (hu)
JP (1)	JP6050902B2 (hu)
KR (1)	KR101858890B1 (hu)
CN (1)	CN106456717B (hu)
AP (1)	AP2016009525A0 (hu)
AR (1)	AR100155A1 (hu)
AU (1)	AU2015256355B2 (hu)
BR (1)	BR112016024357B1 (hu)
CA (1)	CA2945188C (hu)
CL (1)	CL2016002772A1 (hu)
CY (2)	CY1121669T1 (hu)
DK (2)	DK3536380T3 (hu)
EA (1)	EA031134B1 (hu)
ES (2)	ES2891983T3 (hu)
HR (2)	HRP20190777T1 (hu)
HU (2)	HUE044370T2 (hu)
IL (1)	IL248350B (hu)
JO (1)	JO3624B1 (hu)
LT (2)	LT3140008T (hu)
MA (1)	MA39441A1 (hu)
ME (1)	ME03384B (hu)
MX (1)	MX367521B (hu)
NZ (1)	NZ724919A (hu)
PE (1)	PE20161408A1 (hu)
PH (1)	PH12016502195B1 (hu)
PL (2)	PL3536380T3 (hu)
PT (2)	PT3140008T (hu)
RS (2)	RS62291B1 (hu)
SG (1)	SG11201608424WA (hu)
SI (2)	SI3536380T1 (hu)
TN (1)	TN2016000443A1 (hu)
TR (1)	TR201906843T4 (hu)
TW (1)	TWI685348B (hu)
UA (1)	UA124919C2 (hu)
WO (1)	WO2015171484A1 (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE032287T2 (hu)	2008-03-18	2017-09-28	Novo Nordisk As	Proteáz-stabilizált, acilált inzulin-analógok
CN107952065A (zh)	2012-11-13	2018-04-24	阿道恰公司	包含经取代阴离子化合物的速效胰岛素制剂
ES2805367T3 (es)	2013-01-11	2021-02-11	Corsair Pharma Inc	Profármacos de treprostinil
US9505737B2 (en)	2013-01-11	2016-11-29	Corsair Pharma, Inc.	Treprostinil derivative compounds and methods of using same
ES2972423T3 (es) *	2015-07-28	2024-06-12	Lilly Co Eli	Preparado farmacéutico para mejorar la absorción y la acción hipoglucemiante postprandial de la insulina
JO3749B1 (ar) *	2015-08-27	2021-01-31	Lilly Co Eli	تركيبات إنسولين سريعة المفعول
AU2017211410B2 (en) *	2016-01-29	2022-10-13	Mannkind Corporation	Dry powder inhaler
GB201607918D0 (en)	2016-05-06	2016-06-22	Arecor Ltd	Novel formulations
JP7220650B2 (ja)	2016-09-26	2023-02-10	ユナイテッドセラピューティクスコーポレイション	トレプロスチニルプロドラッグ
CN109803639B (zh)	2016-09-29	2024-01-02	艾瑞克有限公司	新制剂
WO2018109162A1 (en)	2016-12-16	2018-06-21	Novo Nordisk A/S	Insulin containing pharmaceutical compositions
GB201707187D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707188D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707189D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
CR20190522A (es)	2017-06-01	2020-01-15	Lilly Co Eli	Composiciones de insulina de rápida acción
IL277731B2 (en) *	2018-04-04	2024-03-01	Arecor Ltd	Medical infusion pump system for the delivery of an insulin compound
EP3773474A1 (en)	2018-04-04	2021-02-17	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
WO2019193351A1 (en)	2018-04-04	2019-10-10	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
WO2019243627A1 (fr)	2018-06-23	2019-12-26	Adocia	Dispositif pour injecter une solution d'insuline(s)
FR3083985A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
BR112021002200B1 (pt)	2018-09-18	2024-03-12	Eli Lilly And Company	Sal erbumina de trepostinila
US10799564B1 (en) *	2019-05-06	2020-10-13	Baxter International Inc.	Insulin premix formulation and product, methods of preparing same, and methods of using same
WO2021009027A1 (en) *	2019-07-12	2021-01-21	Novo Nordisk A/S	High concentration insulin formulation
EP4017588A1 (en)	2019-08-23	2022-06-29	United Therapeutics Corporation	Treprostinil prodrugs
GB202004814D0 (en)	2020-04-01	2020-05-13	Arecor Ltd	Novel formulations
JP2023523557A (ja)	2020-04-17	2023-06-06	ユナイテッドセラピューティクスコーポレイション	間質性肺疾患の治療における使用のためのトレプロスチニル
CA3180230A1 (en)	2020-06-09	2021-12-16	Hitesh Batra	Fumaryl diketopiperidine prodrugs of treprostinil
WO2022002008A1 (zh) *	2020-06-30	2022-01-06	江苏恒瑞医药股份有限公司	速效胰岛素组合物及其医药用途
AU2021401921A1 (en)	2020-12-14	2023-07-06	United Therapeutics Corporation	Methods of treating disease with treprostinil prodrugs
IL305510A (en)	2021-03-03	2023-10-01	United Therapeutics Corp	A dry powder preparation of terprostinil and its prodrug that will additionally contain (E)-3,6-bis[4-(N-carbonyl-2-propenyl)amidobiotyl]-2,5-dictopiperazine (FDKP)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2740953A1 (de)	1977-09-12	1979-03-22	Thera Ges Fuer Patente	Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
JPH10251146A (ja)	1997-03-11	1998-09-22	Toray Ind Inc	糖尿病性神経障害の治療方法
US7238663B2 (en) *	2001-08-28	2007-07-03	Eli Lilly And Company	Pre-mixes of GLP-1 and basal insulin
ES2360182T3 (es) *	2002-05-07	2011-06-01	Novo Nordisk A/S	Formulaciones solubles que comprenden insulina monomérica e insulina acilada.
CA2562614C (en) *	2004-04-12	2013-09-17	United Therapeutics, Inc.	Use of treprostinil to treat neuropathic diabetic foot ulcers
CA2697057A1 (en) *	2007-08-22	2009-02-26	Gilead Colorado, Inc.	Therapy for complications of diabetes
DK2626093T3 (en)	2008-08-28	2014-02-24	Hoffmann La Roche	DEVICE FOR INCREASING HYPODERMIC insulin absorption
CA2737350A1 (en) *	2008-09-25	2010-04-01	Aradigm Corporation	Deep lung pulmonary delivery of treprostinil
RU2533217C3 (ru)	2009-06-26	2020-12-21	Ново Нордиск А/С	Препарат, содержащий инсулин, никотинамид и аминокислоту
BR112012011237A2 (pt) *	2009-11-13	2019-09-24	Univ Tokyo	agente terapêutico e profilático para diabetes
CA2821613A1 (en)	2010-12-14	2012-06-21	Novo Nordisk A/S	Preparation comprising insulin, nicotinamide and an amino acid
JP6092867B2 (ja) *	2011-08-12	2017-03-08	アセンディスファーマエー／エス	担体連結しているトレプロスチニルプロドラッグ
US9381247B2 (en) *	2012-04-16	2016-07-05	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
WO2015031709A1 (en)	2013-08-30	2015-03-05	Perosphere, Inc.	Rapid acting injectable formulations comprising a peptide and a vasodilatory agent
US20150273022A1 (en)	2014-02-10	2015-10-01	Biodel Inc.	Stabilized ultra-rapid-acting insulin formulations

2015
- 2015-04-21 TW TW104112752A patent/TWI685348B/zh active
- 2015-04-21 JO JOP/2015/0079A patent/JO3624B1/ar active
- 2015-04-22 AR ARP150101208A patent/AR100155A1/es not_active Application Discontinuation
- 2015-05-04 LT LTEP15723388.3T patent/LT3140008T/lt unknown
- 2015-05-04 SG SG11201608424WA patent/SG11201608424WA/en unknown
- 2015-05-04 DK DK19161129.2T patent/DK3536380T3/da active
- 2015-05-04 ES ES19161129T patent/ES2891983T3/es active Active
- 2015-05-04 EA EA201691911A patent/EA031134B1/ru active Protection Beyond IP Right Term
- 2015-05-04 HU HUE15723388 patent/HUE044370T2/hu unknown
- 2015-05-04 DK DK15723388.3T patent/DK3140008T3/da active
- 2015-05-04 CA CA2945188A patent/CA2945188C/en active Active
- 2015-05-04 ME MEP-2019-126A patent/ME03384B/me unknown
- 2015-05-04 PT PT15723388T patent/PT3140008T/pt unknown
- 2015-05-04 US US14/781,342 patent/US9439952B2/en active Active
- 2015-05-04 MA MA39441A patent/MA39441A1/fr unknown
- 2015-05-04 EP EP21183262.1A patent/EP3943155A1/en not_active Withdrawn
- 2015-05-04 PL PL19161129T patent/PL3536380T3/pl unknown
- 2015-05-04 MX MX2016014643A patent/MX367521B/es active IP Right Grant
- 2015-05-04 SI SI201531655T patent/SI3536380T1/sl unknown
- 2015-05-04 ES ES15723388T patent/ES2733639T3/es active Active
- 2015-05-04 PT PT191611292T patent/PT3536380T/pt unknown
- 2015-05-04 AP AP2016009525A patent/AP2016009525A0/en unknown
- 2015-05-04 RS RS20211085A patent/RS62291B1/sr unknown
- 2015-05-04 EP EP19161129.2A patent/EP3536380B8/en active Active
- 2015-05-04 TR TR2019/06843T patent/TR201906843T4/tr unknown
- 2015-05-04 SI SI201530716T patent/SI3140008T1/sl unknown
- 2015-05-04 TN TN2016000443A patent/TN2016000443A1/en unknown
- 2015-05-04 LT LTEP19161129.2T patent/LT3536380T/lt unknown
- 2015-05-04 KR KR1020167031043A patent/KR101858890B1/ko active Active
- 2015-05-04 UA UAA201611280A patent/UA124919C2/uk unknown
- 2015-05-04 RS RS20190582A patent/RS58726B1/sr unknown
- 2015-05-04 BR BR112016024357-9A patent/BR112016024357B1/pt active IP Right Grant
- 2015-05-04 PE PE2016002179A patent/PE20161408A1/es unknown
- 2015-05-04 NZ NZ724919A patent/NZ724919A/en unknown
- 2015-05-04 WO PCT/US2015/029010 patent/WO2015171484A1/en active Application Filing
- 2015-05-04 CN CN201580024110.4A patent/CN106456717B/zh active Active
- 2015-05-04 JP JP2015563152A patent/JP6050902B2/ja active Active
- 2015-05-04 EP EP15723388.3A patent/EP3140008B1/en active Active
- 2015-05-04 HU HUE19161129A patent/HUE055742T2/hu unknown
- 2015-05-04 PL PL15723388T patent/PL3140008T3/pl unknown
- 2015-05-04 AU AU2015256355A patent/AU2015256355B2/en active Active
2016
- 2016-09-08 US US15/259,101 patent/US10172922B2/en active Active
- 2016-10-13 IL IL248350A patent/IL248350B/en active IP Right Grant
- 2016-11-02 CL CL2016002772A patent/CL2016002772A1/es unknown
- 2016-11-04 PH PH12016502195A patent/PH12016502195B1/en unknown
2019
- 2019-04-25 HR HRP20190777TT patent/HRP20190777T1/hr unknown
- 2019-05-31 CY CY20191100581T patent/CY1121669T1/el unknown
2021
- 2021-08-20 CY CY20211100747T patent/CY1124454T1/el unknown
- 2021-09-07 HR HRP20211415TT patent/HRP20211415T1/hr unknown

Also Published As

Publication number	Publication date
HRP20211415T1 (hr)	2021-12-10
DK3536380T3 (da)	2021-08-02
DK3140008T3 (da)	2019-06-24
PL3140008T3 (pl)	2019-09-30
MX367521B (es)	2019-08-26
ES2733639T3 (es)	2019-12-02
MA39441A1 (fr)	2017-06-30
BR112016024357B1 (pt)	2022-08-23
HUE044370T2 (hu)	2019-10-28
KR101858890B1 (ko)	2018-05-16
IL248350B (en)	2020-03-31
CY1124454T1 (el)	2022-07-22
JO3624B1 (ar)	2020-08-27
SI3140008T1 (sl)	2019-06-28
ME03384B (me)	2020-01-20
TN2016000443A1 (en)	2018-04-04
EP3536380B8 (en)	2021-09-22
KR20160133567A (ko)	2016-11-22
UA124919C2 (uk)	2021-12-15
PH12016502195A1 (en)	2017-02-06
IL248350A0 (en)	2016-11-30
EA031134B1 (ru)	2018-11-30
LT3140008T (lt)	2019-05-27
AP2016009525A0 (en)	2016-10-31
BR112016024357A2 (pt)	2017-10-10
RS62291B1 (sr)	2021-09-30
ES2891983T3 (es)	2022-02-01
JP2016523807A (ja)	2016-08-12
AR100155A1 (es)	2016-09-14
LT3536380T (lt)	2021-08-10
PT3536380T (pt)	2021-09-02
CA2945188C (en)	2018-12-11
PT3140008T (pt)	2019-06-25
SI3536380T1 (sl)	2021-09-30
AU2015256355A1 (en)	2016-10-27
PH12016502195B1 (en)	2017-02-06
TW201625291A (zh)	2016-07-16
AU2015256355B2 (en)	2017-09-14
MX2016014643A (es)	2017-03-06
HRP20190777T1 (hr)	2019-08-23
CL2016002772A1 (es)	2017-06-09
WO2015171484A1 (en)	2015-11-12
CY1121669T1 (el)	2020-07-31
US20160367640A1 (en)	2016-12-22
CN106456717A (zh)	2017-02-22
US20160129087A1 (en)	2016-05-12
EP3140008A1 (en)	2017-03-15
EP3536380A1 (en)	2019-09-11
TWI685348B (zh)	2020-02-21
PE20161408A1 (es)	2016-12-28
JP6050902B2 (ja)	2016-12-21
PL3536380T3 (pl)	2021-12-27
NZ724919A (en)	2018-01-26
US9439952B2 (en)	2016-09-13
EP3536380B1 (en)	2021-07-07
TR201906843T4 (tr)	2019-05-21
EA201691911A1 (ru)	2017-02-28
RS58726B1 (sr)	2019-06-28
CA2945188A1 (en)	2015-11-12
SG11201608424WA (en)	2016-11-29
EP3140008B1 (en)	2019-04-17
EP3943155A1 (en)	2022-01-26
US10172922B2 (en)	2019-01-08
CN106456717B (zh)	2020-01-17

Publication	Publication Date	Title
IL248350A0 (en)	2016-11-30	Fast-acting insulin preparations
RS63174B1 (sr)	2022-05-31	Kompozicije insulina brzog dejstva
ZA201800511B (en)	2019-07-31	Rapid-acting insulin compositions
GB201410905D0 (en)	2014-08-06	Composition
GB201404178D0 (en)	2014-04-23	Composition
GB201403017D0 (en)	2014-04-09	Composition
IL252977A0 (en)	2017-08-31	preparation
GB201414910D0 (en)	2014-10-08	Composition
GB201403561D0 (en)	2014-04-16	Composition
GB201414555D0 (en)	2014-10-01	Composition
GB201410493D0 (en)	2014-07-30	Composition
GB201415483D0 (en)	2014-10-15	Composition
GB201404390D0 (en)	2014-04-23	Composition
GB201403550D0 (en)	2014-04-16	Composition
GB201402648D0 (en)	2014-04-02	Composition
IL270975A (en)	2020-01-30	Fast-acting insulin preparations
IL250781A0 (en)	2017-04-30	preparation
GB201421660D0 (en)	2015-01-21	Composition
GB201412414D0 (en)	2014-08-27	Composition
GB201412314D0 (en)	2014-08-27	Composition
GB201402487D0 (en)	2014-03-26	Composition
GB201401510D0 (en)	2014-03-12	Composition